Stockreport

Novo to launch Ozempic pill for diabetes in second quarter of 2026 [BNN Bloomberg (Canada)]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF The company said the U.S. Food and Drug Administration has approved Ozempic tablets in 1.5 milligram, 4 milligram, and 9 milligram doses. The new Ozempic name is inte [Read more]